Homoeopathic treatment of psoriasis (a chronic skin disease)

Recruiting

• Conditions: Psoriasis

• Registration Number: CTRI/2017/05/008559
• Lead Sponsor: National Institute of Homoeopathy Ministry of AYUSH Govt of India

Brief Summary

Psoriasis is currently understood as an immune system disturbance with inflammatory skin manifestation. Chronicity and lack of causal therapies lead to permanence of physical and psycho-social suffering, increased costs, and frequent dissatisfaction with offered treatments. Treatment must be sustained to prevent rebounds, placing a burden of side-effects, toxicity, and possible long-term risks. In situations like this, patients tend to look for alternative approaches such as homeopathy. Unfortunately, the efficacy and effectiveness of homeopathy in psoriasis treatment has not been researched well so far. In this clinical audit, the investigator intends to assess the utility of individualized homoeopathic treatment in 100 patients suffering from psoriasis. Patients will be enrolled in this observational trial from the outpatients of National Institute of Homoeopathy, Ministry of AYUSH, Govt. of India from May 2017 onward. Primary outcome is Psoriasis Area and Severity Index (PASI). Secondary outcomes are Psoriasis Disability Index (PDI) and Dermatological Quality of Life Index (DQLI). All the outcomes are to be measured at baseline and after 6 months. The generated results will be analyzed and will be published in scientific journals.

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2017-05-15
• Study Start: 2017-05-22

Recruitment & Eligibility

• Status: Open to Recruitment
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• Patients suffering from psoriasis over 3 months 2.
• Age 18-60 years 3.
• Both sexes 4.
• Patients willing to take part in the study and giving written consent.

Exclusion Criteria

• Patients who are too sick for consultation 2.
• Unable to read patient information sheets and not giving consent to take part 3.
• Psoriasis with complications like erythroderma and pustules 4.
• Diagnosed cases of unstable psychiatric illness or other systemic disease affecting quality of life 5.
• Currently receiving homeopathic treatment for chronic condition(s) 6.
• Pregnant and lactating women 7.
• Self-reported immune-compromised state 8.
• Substance abuse and/or dependence.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Psoriasis Area Scoring Index (PASI)	Baseline and 6 months

Secondary Outcome Measures

Name	Time	Method
Dermatological Quality of Life Index (DQLI)	Baseline and 6 months
Psoriasis Disability Index (PDI)	Baseline and 6 months

Trial Locations

Locations (1)

National Institute of Homoeopathy, Govt. of India; 🇮🇳 Kolkata, WEST BENGAL, India

National Institute of Homoeopathy, Govt. of India

🇮🇳Kolkata, WEST BENGAL, India

Anaitulah Ahmad Mir

Principal investigator

9419039499

civildefence12@gmail.com